Effects of hyperacute blood pressure and heart rate on stroke outcomes after intravenous tissue plasminogen activator

被引:27
|
作者
Tomii, Yasuhiro [1 ]
Toyoda, Kazunori [1 ]
Nakashima, Takahiro [1 ]
Nezu, Tomohisa [1 ]
Koga, Masatoshi [2 ]
Yokota, Chiaki [1 ]
Nagatsuka, Kazuyuki [3 ]
Minematsu, Kazuo [1 ]
机构
[1] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka 5658565, Japan
[2] Natl Cerebral & Cardiovasc Ctr, Div Stroke Care Unit, Suita, Osaka 5658565, Japan
[3] Natl Cerebral & Cardiovasc Ctr, Dept Neurol, Suita, Osaka 5658565, Japan
基金
日本学术振兴会;
关键词
blood pressure; heart rate; hypertension; outcome; stroke; thrombolysis; tissue plasminogen activator; ACUTE ISCHEMIC-STROKE; SAFE IMPLEMENTATION; PROGNOSTIC-SIGNIFICANCE; DIFFERENT SUBTYPES; CLINICAL-TRIAL; THROMBOLYSIS; ALTEPLASE; ASSOCIATION; VARIABILITY; PREDICTORS;
D O I
10.1097/HJH.0b013e32834a764e
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background and purpose The present study clarifies associations between stroke outcomes after intravenous tissue plasminogen activator (tPA) and blood pressure (BP) as well as heart rate (HR) profiles. Methods We assessed 125 patients with stroke who received tPA within 3 h of onset. We obtained baseline, mean, maximum, minimum, and coefficient of variation values for BP and HR during the initial 24 h. The primary outcome was independence at 3 months corresponding to a modified Rankin Scale score of 2 or less. The secondary outcomes were early neurological improvement at 24 h and intracerebral hemorrhage (ICH) within 36 h. Results Among the patients, 64 (51%) achieved independence, 66 (53%) early improvement, and 26 (21%) developed ICH. The 24-h time courses of SBP (P = 0.033), pulse pressure (PP, P = 0.007), and HR (P < 0.001) were lower among patients who reached independence than among those who did not. After multivariate adjustment, 24-h mean levels of SBP (odds ratio 0.69, 95% confidence interval 0.48-0.97, per 10-mmHg increase), PP (0.63, 0.41-0.94), and HR (0.59, 0.42-0.80, per 10-bpm increase) were inversely associated with independence, as were their maximum and minimum values. In particular, mean SBP values were inversely associated with independence at 8-16 and 16-24 h (0.73, 0.54-0.97 and 0.66, 0.47-0.91, respectively), but not at 0-8 h (0.79, 0.57-1.07). Baseline and maximum SBP were inversely associated with early improvement. Maximum and coefficient of variation of SBP were associated with ICH. Conclusion Lower SBP, PP, and HR values during the initial 24 h after tPA, especially at 8 h thereafter, were associated with independence at 3 months. J Hypertens 29:1980-1987 (C) 2011 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:1980 / 1987
页数:8
相关论文
共 50 条
  • [31] Diagnostic impact of baseline cerebral blood flow in patients with acute ischemic stroke prior to intravenous recombinant tissue plasminogen activator therapy
    Ito, Masaki
    Yoshimoto, Tetsuyuki
    Kawabori, Masahito
    Fujimoto, Shin
    Yamauchi, Tohru
    Yamaguchi, Hideshi
    Tokuda, Kouichi
    Kaneko, Sadao
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 (08) : 1464 - 1469
  • [32] Recanalization Rate and Clinical Outcomes of Intravenous Tissue Plasminogen Activator Administration for Large Vessel Occlusion Stroke Patients
    Lee, Min-Hyung
    Im, Sang-Hyuk
    Jo, Kwang Wook
    Yoo, Do-Sung
    JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, 2023, 66 (02) : 144 - 154
  • [33] Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator A Science Advisory From the American Heart Association/American Stroke Association
    del Zoppo, Gregory J.
    Saver, Jeffrey L.
    Jauch, Edward C.
    Adams, Harold P., Jr.
    STROKE, 2009, 40 (08) : 2945 - 2948
  • [34] Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA)
    Eissa, A.
    Krass, I.
    Bajorek, B. V.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2012, 37 (06) : 620 - 629
  • [35] INTRAVENOUS TISSUE PLASMINOGEN ACTIVATOR FOR STROKE: A REVIEW OF THE ECASS III RESULTS IN RELATION TO PRIOR CLINICAL TRIALS
    Cronin, Carolyn A.
    JOURNAL OF EMERGENCY MEDICINE, 2010, 38 (01) : 99 - 105
  • [36] Vascular Aphasia Outcome after Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis for Ischemic Stroke
    Jacquin, A.
    Virat-Brassaud, M. -E.
    Rouaud, O.
    Osseby, G. -V.
    Aboa-Eboule, C.
    Hervieu, M.
    Menassa, M.
    Ricolfi, F.
    Giroud, M.
    Bejot, Y.
    EUROPEAN NEUROLOGY, 2014, 71 (5-6) : 288 - 295
  • [37] Does High Cerebral Microbleed Burden Increase the Risk of Intracerebral Hemorrhage After Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke?
    Arca, Karissa N.
    Demaerschalk, Bart M.
    Almader-Douglas, Diana
    Wingerchuk, Dean M.
    O'Carroll, Cumara B.
    NEUROLOGIST, 2019, 24 (01) : 40 - 43
  • [38] Risk factors and outcomes of intravenous tissue plasminogen activator and endovascular thrombectomy utilization amongst pediatrics acute ischemic stroke
    Malik, Preeti
    Patel, Urvish K.
    Kaul, Surabhi
    Singla, Ramit
    Kavi, Tapan
    Arumaithurai, Kogulavadanan
    Jani, Vishal B.
    INTERNATIONAL JOURNAL OF STROKE, 2021, 16 (02) : 172 - 183
  • [39] Acute ischemic stroke: improving access to intravenous tissue plasminogen activator
    Turner, Ashby C.
    Schwamm, Lee H.
    Etherton, Mark R.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2020, 18 (05) : 277 - 287
  • [40] Intravenous recombinant tissue plasminogen activator in a pregnant woman with cardioembolic stroke
    Wiese, Kathleen M.
    Talkad, Arun
    Mathews, Maureen
    Wang, David
    STROKE, 2006, 37 (08) : 2168 - 2169